Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05471414 · ClinicalTrials.gov registry record · NA

Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate Cancer

A NA study of Prostate Cancer, sponsored by Weill Medical College of Cornell University.

Active
Registry status
NA
Development phase
76
Enrollment target
3
Study locations

NCT05471414 is a NA study of Prostate Cancer that is active but no longer recruiting, run by Weill Medical College of Cornell University. The registered enrollment target is 76 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (87% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05471414, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by Weill Medical College of Cornell University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
76 participants
Enrollment target
3
Study locations

Study Summary

The study is comparing the effect on weight of providing home-delivered whole-food, plant-based meals versus standard, general nutritional counseling to men with prostate cancer on androgen-deprivation therapy (ADT).

Conditions Studied

Interventions

  • BEHAVIORAL Whole-food, Plant-Based Diet
  • BEHAVIORAL General Nutritional Counseling

Study Locations (3)

New York

  • Weill Cornell Medicine - New York
  • Columbia University Medical Center - New York

Maryland

  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center - Baltimore

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2022-09-22
Est. Completion 2027-04
Phase NA

What the Registry Record Tells You About NCT05471414

The ClinicalTrials.gov registry entry for NCT05471414 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (87% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Whole-food, Plant-Based Diet is the first listed.

NCT05471414 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, Maryland.

Frequently Asked Questions

What is clinical trial NCT05471414 about?

NCT05471414 is a clinical study titled "Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate Cancer". The study is comparing the effect on weight of providing home-delivered whole-food, plant-based meals versus standard, general nutritional counseling to men with prostate cancer on androgen-deprivation therapy (ADT).

What is the current status of trial NCT05471414?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2022-09-22. Estimated completion is 2027-04.

What conditions does trial NCT05471414 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT05471414?

The interventions under investigation include: Whole-food, Plant-Based Diet (BEHAVIORAL), General Nutritional Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT05471414?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05471414 being conducted?

This trial has 3 study locations across Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.